Faruqi and Faruqui, LLP Logo
Share this page

Diplomat Pharmacy, Inc. (DPLO)

NYSE:DPLO

Summary

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Diplomat Pharmacy, Inc.  To Contact The Firm Before Lead Plaintiff Deadline

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE:DPLO) of the January 9, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the Eastern District of Michigan on behalf of all those who purchased Diplomat stock or options between October 9, 2014 and November 2, 2016 (the “Class Period”).  The case, Zimmerman v. Diplomat Pharmacy, Inc. et al, No. 16-cv-14005 was filed on November 10, 2016, and has been assigned to Judge Stephanie Dawkins Davis.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company lacked adequate internal controls over its financial reporting; (2) as a result the Company could not adequately calculate direct and indirect remuneration (“DIR”) fees; (3) the Company’s hepatitis C segment was not performing as previously disclosed to investors; (4) and therefore, the Company had overstated its full-year 2016 guidance.

Specifically, on November 2, 2016, Diplomat announced third quarter 2016 results that were below investors’ expectations and lowered its full year 2016 guidance.  The Company’s Chief Executive Officer attributed the poor operating results to “softness in the hepatitis C business” and DIR fees.

On this news, Diplomat’s share price fell from $22.38 per share on November 2, 2016 to a closing price of $12.95 on November 3, 2016—a $9.43or a 42.1% drop.

Take Action

If you invested in Diplomat stock or options between October 9, 2014 and November 2, 2016 and would like to discuss your legal rights, please fill out the form below. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Diplomat’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Request Information

Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you.

  • Case:
    Diplomat Pharmacy, Inc. (DPLO)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 11/15/2016

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.